ICJIM
Intercontinental Journal of Internal Medicine

The Intercontinental Journal of Internal Medicine aims to publish issues related to all fields of internal medicine of the highest scientific and clinical value at an international level and accepts articles on these topics. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

eISSN: 2980-0846
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Review
Acute phase reactants
Abstract
The serum concentrations of certain proteins are altered in various conditions such as infection, trauma, inflammatory arthritis, malignancy, autoimmune and systemic inflammatory diseases. These proteins are known as positive or negative acute phase reactants. While albumin and transferrin belong to the negative acute phase reactants, alpha-1-acid glycoprotein, alpha-1-antitrypsin, alpha-2-macroglobulin, C-reactive protein, ceruloplasmin, haptoglobin, serum amyloid A and fibrinogen are known as positive acute phase reactants. This review discusses the clinical use of C-reactive protein, erythrocyte sedimentation rate and procalcitonin.

Keywords : Acute phase reactants, CRP, ESR, procalcitonin

Download Article


1. Powanda MC, Moyer ED. A brief, highly selective history of acute phase proteins as indicators of infection, inflammation and injury. Inflammopharmacology. 2021;29(3):897-901.
2. Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci. 1982;389:39-48.
3. Pathak A, Agrawal A. Evolution of C-reactive protein. Front Immunol. 2019;10:943.
4. Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930;52(4):561-571.
5. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
6. Potempa LA, Siegel JN, Fiedel BA, Potempa RT, Gewurz H. Expression, detection and assay of a neoantigen (Neo-CRP) associated with a free, human C-reactive protein subunit. Mol Immunol. 1987;24(5):531-541.
7. Kushner I, Antonelli MJ. What should we regard as an “elevated” C-reactive protein level?. Ann Intern Med. 2015;163(4):326.
8. Aziz N, Fahey JL, Detels R, Butch AW. Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood. Clin Diagn Lab Immunol. 2003;10(4):652-657.
9. Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol. 2005;117(2):104-111.
10. Rhodes B, Fürnrohr BG, Vyse TJ. C-reactive protein in rheumatology: biology and genetics. Nat Rev Rheumatol. 2011;7(5):282-289.
11. Rizo-Téllez SA, Sekheri M, Filep JG. C-reactive protein: a target for therapy to reduce inflammation. Front Immunol. 2023;14:1237729.
12. Szalai AJ, VanCott JL, McGhee JR, Volanakis JE, Benjamin WH Jr. Human C-reactive protein is protective against fatal Salmonella enterica serovar typhimurium infection in transgenic mice. Infect Immun. 2000;68(10):5652-5656.
13. Kingsley A, Jones V. Diagnosing wound infection: the use of C-reactive protein. Wounds UK. 2008;4(4):32-46.
14. Özsoy Z, Bilgin E, Aksun MS, Eroğlu İ, Kalyoncu U. Extremely high erythrocyte sedimentation rate revisited in rheumatic diseases: a single-center experience. Turk J Med Sci. 2022;52(6):1889-1899.
15. Bedell SE, Bush BT. Erythrocyte sedimentation rate. From folklore to facts. Am J Med. 1985;78(6 Pt 1):1001-1009.
16. Grzybowski A, Sak JJ. Who discovered the erythrocyte sedimentation rate?. J Rheumatol. 2011;38(7):1521-1523.
17. Piva E, Sanzari MC, Servidio G, Plebani M. Length of sedimentation reaction in undiluted blood (erythrocyte sedimentation rate): variations with sex and age and reference limits. Clin Chem Lab Med. 2001;39(5):451-454.
18. Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed). 1983;286(6361): 266.
19. Litao MK, Kamat D. Erythrocyte sedimentation rate and C-reactive protein: how best to use them in clinical practice. Pediatr Ann. 2014; 43(10):417-420.
20. Daniels LM, Tosh PK, Fiala JA, Schleck CD, Mandrekar JN, Beckman TJ. Extremely elevated erythrocyte sedimentation rates: associations with patients’ diagnoses, demographic characteristics, and comorbidities. Mayo Clin Proc. 2017;92(11):1636-1643.
21. Fincher RM, Page MI. Clinical significance of extreme elevation of the erythrocyte sedimentation rate. Arch Intern Med. 1986;146(8):1581-1583.
22. Wiedermann FJ, Kaneider N, Egger P, et al. Migration of human monocytes in response to procalcitonin. Crit Care Med. 2002;30(5): 1112-1117.
23. Vijayan AL, Vanimaya, Ravindran S, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 2017;5:51.
24. Taylor R, Jones A, Kelly S, Simpson M, Mabey J. A review of the value of procalcitonin as a marker of infection. Cureus. 2017;9(4):1148.
25. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515-518.
26. Hoeboer SH, van der Geest PJ, Nieboer D, Groeneveld AB. The diagnostic accuracy of procalcitonin for bacteraemia: a systematic review and meta-analysis. Clin Microbiol Infect. 2015;21(5):474-481.
27. Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions: a systematic review of randomized controlled trials and recommendations for clinical algorithms. Arch Intern Med. 2011;171(15):1322-1331.
28. Alba GA, Truong QA, Gaggin HK, et al; Global Research on Acute Conditions Team (GREAT) Network. Diagnostic and prognostic utility of procalcitonin in patients presenting to the emergency department with dyspnea. Am J Med. 2016;129(1):96-104.e7.
29. Müller B, White JC, Nylén ES, Snider RH, Becker KL, Habener JF. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86(1):396-404.
30. Linscheid P, Seboek D, Zulewski H, Keller U, Müller B. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology. 2005;146(6):2699-2708.
31. Kamat IS, Ramachandran V, Eswaran H, Guffey D, Musher DM. Procalcitonin to distinguish viral from bacterial pneumonia: a systematic review and meta-analysis. Clin Infect Dis. 2020;70(3):538-542.
32. Azijli K, Minderhoud TC, de Gans CJ, Lieveld AWE, Nanayakkara PWB. Optimal use of procalcitonin to rule out bacteremia in patients with possible viral infections. J Am Coll Emerg Physicians Open. 2022; 3(3):e12621.
33. Rodríguez AH, Avilés-Jurado FX, Díaz E, et al. Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: a CHAID decision-tree analysis. J Infect. 2016;72(2):143-151.
34. Relph KA, Russell CD, Fairfield CJ, et al. Procalcitonin is not a reliable biomarker of bacterial coinfection in people with coronavirus disease 2019 undergoing microbiological investigation at the time of hospital admission. Open Forum Infect Dis. 2022;9(5):ofac179.
35. Gul S, Ozturk DB, Kisa U, Kacmaz B, Yesilyurt M. Procalcitonin level and its predictive effect on mortality in Crimean-Congo hemorrhagic fever patients. Jpn J Infect Dis. 2015;68(6):511-513.
Article available in :
Volume 2, Issue 3, 2024
Page : 74-76
https://doi.org/10.51271/ICJIM-0040
Article Information
Received : 11 Haz 2024
Accepted : 24 Ağu 2024
Published : 28 Ağu 2024
Corresponding Author :

İlknur Akkuş: Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Kırıkkale University, Kırıkkale, Turkey

[email protected]
Citation : Akkuş İ, Kaçmaz B. Acute phase reactants. Intercont J Int Med. 2024;2(3):74-76.

Read: 313
Cited: 0
Download : 127
_Footer